• Something wrong with this record ?

Increased glutamate and deep brain atrophy can predict the severity of multiple sclerosis

H. Polacek, E. Kantorova, P. Hnilicova, M. Grendar, K. Zelenak, E. Kurca

. 2019 ; 163 (1) : 45-53. [pub] 20180716

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19036089

OBJECTIVE: In multiple sclerosis (MS), deep grey matter (DGM) atrophy has been recognised as a crucial component of the disease that presents early and it has been associated with disability. Although the precise mechanism underlying grey matter atrophy is unknown, several hypotheses have been postulated. Our previous research pointed to correlations of hypothalamic metabolic alterations with clinical outcomes of MS, therefore we decided to further test the relationship of these alterations with DGM atrophy. METHODS: We used 1H-Magnetic Resonance spectroscopy (1H-MRS) of the hypothalamus to test its metabolites in 26 patients with RRMS and 22 healthy age-matched controls. DGM atrophy was evaluated by simple planimetry of third ventricular width on the hypothalamic level (3VW) in T1 weighted MRI pictures. Metabolite ratios of N-acetyl aspartate (NAA), choline (Cho), glutamate and glutamine (Glx), myo-inositol (mIns) and creatine (Cr) were correlated with Multiple Sclerosis Severity Scale (MSSS) and 3VW. RESULTS: Metabolite concentrations were compared between patients and controls using multiple regression models allowing for age, 3VW and metabolites. It revealed that the only relevant predictors of MSSS were 3VW and Glx/NAA. At a significance level of P<0.05, a unit increase of 3VW was associated with a 0.35 increase of MSSS, for a typical value of Glx/NAA; P value 0.0039. A unit increase of Glx/NAA was associated with a 0.93 increase of MSSS, for a typical value of atrophy; P value 0.090. There were significant linear correlations between Glx/Cr and MSSS, Glx/NAA and MSSS, and between mIns/NAA and 3VW. CONCLUSIONS: The results suggest that both NAA and Glx are associated with neurodegeneration of hypothalamic DGM and severe disease course. Glx related 1H-MRS parameters seem to be superior to other metabolites in determining disease burden, independently of otherwise powerful 3VW planimetry. Significantly increased mIns/NAA in MS patients compared to controls point to gliosis, which parallels the atrophy of hypothalamic DGM.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19036089
003      
CZ-PrNML
005      
20191210135119.0
007      
ta
008      
191007s2019 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2018.036 $2 doi
035    __
$a (PubMed)30150790
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Poláček, Hubert $7 xx0173643 $u Clinic of Nuclear Medicine, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Slovak Republic
245    10
$a Increased glutamate and deep brain atrophy can predict the severity of multiple sclerosis / $c H. Polacek, E. Kantorova, P. Hnilicova, M. Grendar, K. Zelenak, E. Kurca
520    9_
$a OBJECTIVE: In multiple sclerosis (MS), deep grey matter (DGM) atrophy has been recognised as a crucial component of the disease that presents early and it has been associated with disability. Although the precise mechanism underlying grey matter atrophy is unknown, several hypotheses have been postulated. Our previous research pointed to correlations of hypothalamic metabolic alterations with clinical outcomes of MS, therefore we decided to further test the relationship of these alterations with DGM atrophy. METHODS: We used 1H-Magnetic Resonance spectroscopy (1H-MRS) of the hypothalamus to test its metabolites in 26 patients with RRMS and 22 healthy age-matched controls. DGM atrophy was evaluated by simple planimetry of third ventricular width on the hypothalamic level (3VW) in T1 weighted MRI pictures. Metabolite ratios of N-acetyl aspartate (NAA), choline (Cho), glutamate and glutamine (Glx), myo-inositol (mIns) and creatine (Cr) were correlated with Multiple Sclerosis Severity Scale (MSSS) and 3VW. RESULTS: Metabolite concentrations were compared between patients and controls using multiple regression models allowing for age, 3VW and metabolites. It revealed that the only relevant predictors of MSSS were 3VW and Glx/NAA. At a significance level of P<0.05, a unit increase of 3VW was associated with a 0.35 increase of MSSS, for a typical value of Glx/NAA; P value 0.0039. A unit increase of Glx/NAA was associated with a 0.93 increase of MSSS, for a typical value of atrophy; P value 0.090. There were significant linear correlations between Glx/Cr and MSSS, Glx/NAA and MSSS, and between mIns/NAA and 3VW. CONCLUSIONS: The results suggest that both NAA and Glx are associated with neurodegeneration of hypothalamic DGM and severe disease course. Glx related 1H-MRS parameters seem to be superior to other metabolites in determining disease burden, independently of otherwise powerful 3VW planimetry. Significantly increased mIns/NAA in MS patients compared to controls point to gliosis, which parallels the atrophy of hypothalamic DGM.
650    _2
$a dospělí $7 D000328
650    _2
$a kyselina asparagová $x analogy a deriváty $x metabolismus $7 D001224
650    _2
$a atrofie $7 D001284
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a kyselina glutamová $x metabolismus $7 D018698
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční spektroskopie $7 D009682
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a roztroušená skleróza $x diagnostické zobrazování $x metabolismus $x patofyziologie $7 D009103
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a thalamus $x patologie $7 D013788
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kantorová, Ema $7 xx0100579 $u Clinic of Neurology, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Slovak Republic
700    1_
$a Hnilicová, Petra $7 xx0253349 $u Biomedical Centre, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Slovak Republic
700    1_
$a Grendár, Marián, $d 1969- $7 xx0242991 $u Biomedical Centre, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Slovak Republic
700    1_
$a Zeleňák, Kamil $7 xx0231390 $u Clinic of Radiodiagnostics, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Slovak Republic
700    1_
$a Kurča, Egon, $d 1964- $7 nlk20050162662 $u Clinic of Neurology, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Slovak Republic
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 163, č. 1 (2019), s. 45-53
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30150790 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191210135416 $b ABA008
999    __
$a ok $b bmc $g 1455257 $s 1074646
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 163 $c 1 $d 45-53 $e 20180716 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20191007

Find record

Citation metrics

Archiving options